Provided by Tiger Trade Technology Pte. Ltd.

Veradermics, Inc.

98.97
+0.83000.85%
Post-market: 98.970.0003+0.00%16:15 EDT
Volume:575.68K
Turnover:57.49M
Market Cap:4.13B
PE:-15.36
High:102.29
Open:99.45
Low:98.82
Close:98.14
52wk High:131.24
52wk Low:32.00
Shares:41.78M
Float Shares:32.29M
Volume Ratio:1.21
T/O Rate:1.78%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-6.4439
EPS(LYR):-111.9114
ROE:-72.06%
ROA:-43.45%
PB:5.08
PE(LYR):-0.88

Loading ...

Citi Keeps Their Buy Rating on Veradermics, Incorporated (MANE)

TIPRANKS
·
Sep 10

Jefferies Remains a Buy on Veradermics, Incorporated (MANE)

TIPRANKS
·
Sep 08

Veradermics Management to Attend September Investor Conferences

Reuters
·
Sep 04

Montanova Capital Reports Disposal of 750,000 Veradermics Common Shares Worth $80.44 Million

Reuters
·
Aug 22

Veradermics Files Form 3 for Chief R&D Officer David Hollander

Reuters
·
Aug 21

Veradermics CEO Reid Alexander Waldman Disposes of Common Shares Worth $7.24 Million

Reuters
·
Aug 19

Veradermics Director John W. Childs Disposes of USD 10.18 Million in Common Shares

Reuters
·
Aug 15

Citi Sticks to Its Buy Rating for Veradermics, Incorporated (MANE)

TIPRANKS
·
Aug 14

Buy Rating Reaffirmed on Strong VDPHL01 Data and Catalyst-Rich Roadmap; Price Target Maintained at $164

TIPRANKS
·
Aug 13

Veradermics Q2 EPS $(0.58) Beats $(0.65) Estimate

Benzinga Earnings
·
Aug 12

Earnings Flash (MANE) Veradermics Posts Q2 Net Loss $23.5M, vs. FactSet Est of $26.8M Loss

MT Newswires Live
·
Aug 11

Veradermics sees cash runway into 2030

TIPRANKS
·
Aug 11

Veradermics Q2 FY26 Net Loss Widens to $23.5 Million; R&D Expense Rises to $18.61 Million

Reuters
·
Aug 11

Veradermics Inc Q2 Operating Expenses USD 29.553 Million

THOMSON REUTERS
·
Aug 11

Press Release: Veradermics Reports Second Quarter 2026 Financial Results and Highlights Recent Corporate and Clinical Progress

Dow Jones
·
Aug 11

Veradermics registers to sell 16.77M shares of common stock

TIPRANKS
·
Aug 08

Veradermics, Incorporated (MANE) Receives a Buy from LifeSci Capital

TIPRANKS
·
Jul 19

Veradermics - Topline Data from Study '306' in Females Anticipated in 1H 2027

THOMSON REUTERS
·
Jul 17

Veradermics to Present Age-subgroup Data from Vdphl01 Male Hair Loss Trial at AAD Innovation Academy

Reuters
·
Jul 17

S&P 500 Futures Fall in Premarket Trading; Elbit Systems, Maase Lead

Dow Jones
·
Jul 17